Clinical Updates & Insights

Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

229 Clinical Updates found
The Most Recent Staging System for Thyroid Cancer Downgrades Almost One-Third of Cases
Clinical Update
The newest edition of the thyroid cancer staging system has increased the age at diagnosis as a prognostic factor by a decade.
cancer smart
Clinical Update
A carefully monitored, multidisciplinary watch-and-wait strategy can result in excellent rectal preservation and pelvic tumor control for a large majority of select patients with rectal cancer who show a clinical complete response after neoadjuvant therapy.
Robert Young, MD
Clinical Update
Treating pituitary tumors with combination immunotherapy may be an effective treatment strategy, especially for tumors that are resistant to temozolomide.
Blood Vials
Clinical Update
Our recent prospective study data provides support for the incorporation of plasma next-generation sequencing (NGS) assays into lung cancer practice guidelines.
Pictured: Dr. Mario Leitao, Jr. and Dr. Nadeem Abu-Rustum
Oncologic outcomes are similar with the use of a sentinel lymph node algorithm compared to performing a full pelvic and paraaortic lymph node dissection in node-negative patients with deeply invasive endometroid endometrial carcinoma.
Nadeem Abu-Rustum, MD, FACOG, FACS
Uterine-preserving surgery results in excellent and similar five-year disease-specific survival compared to hysterectomy in young women with stage IB1 cervical cancer.
Pictured: Martin Weiser, MD
Clinical Update
Our findings indicate that surgical site infections can be reduced effectively over the long term with a hospital-wide implementation of multidisciplinary best practices.
David Hyman, MD and patient
Clinical Update
Sequencing advanced endometrial tumors with the MSK-IMPACT™ assay provides an effective method for detecting microsatellite instability (MSI) and germline cancer predisposition syndromes
Pictured: Michael Zelefsky
Clinical Update
All radiotherapy treatments for prostate cancer should be accompanied by image-guidance of the prostate position to rule out significant setup errors in fractional delivery.
Howard Scher
Clinical Update
Profiling prostate cancer tumors for microsatellite instability (MSI) status with targeted next-generation sequencing can identify patients who may respond better to PD-1/PD-L1 agents.